A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Dan Peer, a global pioneer in mRNA drug development and director of the Laboratory of ... is an mRNA-based vaccine delivered ...

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

Health officials have set targets for how good and how safe a COVID-19 vaccine needs to be, but communicating that to the public can present challenges.

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

Novavax wins narrowed approval for its Covid-19 shot after delay Federal health officials led by RFK Jr. are subjecting Covid shots to greater scrutiny Alastair Grant/AP By Helen Branswell May 17 ...

The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: MRNA), the next-generation healthcare company most famous for developing the ...

After soaring in early pandemic days, Moderna has fallen into the doldrums. An explosive phase of growth may be ahead thanks ...